Afferent Pharmaceuticals Receives $23,000,000 Series A Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d5096069-7f3a-4ce2-acc3-35687ac03d56&Preview=1
Date 12/16/2009
Company Name Afferent Pharmaceuticals
Mailing Address 29 Newbury Street Boston, MA 02116
Company Description Develops medicines to treat chronic pain. Afferent Pharmaceuticals is focused on developing first-in-class medicines to treat chronic pain by targeting P2X3 receptors in nerve fibers. Research shows that P2X3-containing receptors are highly specific to nerve fibers that transmit the sensations of pain and discomfort in response to inflammation or injury, particularly in chronic conditions. P2X3 antagonism represents a breakthrough and potentially transformative approach to treating chronic pain associated with conditions such as osteoarthritis, back pain, visceral pain and neuropathy.